ANN ARBOR, Mich., Sept. 10 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (Amex: AEN) announced today that it will present at the 12th Annual Rodman and Renshaw Healthcare Conference. The conference will be held September 12th to 15th at The New York Palace Hotel in New York, NY. Dr. James S. Kuo, Adeona’s Chief Executive Officer, will provide an update on the Company’s clinical trials on Wednesday, September 15th, at 10:50 am EDT in the Fahnestock Salon (5th Floor).
A live webcast of Adeona’s presentation can be accessed by logging onto http://www.wsw.com/webcast/rrshq18/aen/ or by going to Adeona’s website at www.adeonapharma.com. A replay of the presentation will be archived for 90 days at the same sites.
About Adeona Pharmaceuticals, Inc.
Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food candidate in development. Further information on the company is available at www.adeonapharma.com.
SOURCE Adeona Pharmaceuticals, Inc.
